Isaac Barchas
Director at Immunome. Based in Bothell, Washington.
- Rank
- 2007th of 14,644
- Companies held
- 1
- Largest holding
- IMNM, 100.0% of total
- Latest SEC filing
- Aug 12, 2026
- Listed but not counted
- $5.1M
What the $69.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Immunome IMNM Common Stock | Indirectly (see filing footnote) | 2,042,432 | $16.61 | $33.9M | 49.0% | Form 4, Dec 22, 2025 |
| Immunome IMNM Common Stock | Indirectly (see filing footnote) | 2,031,181 | $16.61 | $33.7M | 48.8% | Form 4, Dec 22, 2025 |
| Immunome IMNM Common Stock | Directly | 92,211 | $16.61 | $1.5M | 2.2% | Form 4, Aug 12, 2026 |
Share counts are the amounts Isaac Barchas reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Isaac Barchas's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Immunome IMNM Common Stock | Indirectly (see filing footnote) Held by a company or fund the insider manages | 308,504 | $16.61 | $5.1M | — | Form 4, Jun 30, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Sold | IMNM | 11,048 | $27.25 | $301K | View |
| Aug 11, 2026 | Sold | IMNM | 62,291 | $26.23 | $1.6M | View |
| Aug 10, 2026 | Sold | IMNM | 10,125 | $26.07 | $264K | View |
| Aug 7, 2026 | Sold | IMNM | 15,248 | $26.06 | $397K | View |
| Aug 6, 2026 | Sold | IMNM | 20,840 | $26.06 | $543K | View |
| Jul 7, 2026 | Sold | IMNM | 16,906 | $24.20 | $409K | View |
| Jul 6, 2026 | Sold | IMNM | 83,094 | $24.11 | $2.0M | View |
| Jul 2, 2026 | Sold | IMNM | 75,665 | $22.35 | $1.7M | View |
| Jul 2, 2026 | Sold | IMNM | 24,335 | $23.33 | $568K | View |
| Jun 30, 2026 | Sold | IMNM | 101,050 | $21.12 | $2.1M | View |
| Dec 22, 2025 | Sold | IMNM | 371,949 | $21.72 | $8.1M | View |
| Dec 22, 2025 | Sold | IMNM | 11,251 | $22.34 | $251K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2004 | Hassane El-Khoury CEO & President, ON Semiconductor. Scottsdale, AZ | $69.3M |
| 2005 | Hanlin Chen See Remarks, China Automotive Systems | $69.3M |
| 2006 | Michael N. Kennedy See Remarks, Antero Resources. Denver, CO | $69.2M |
| 2007 | Isaac Barchas Director, Immunome. Bothell, WA | $69.2M |
| 2008 | Gail Boudreaux President and CEO, Elevance Health. Indianapolis, IN | $69.2M |
| 2009 | Thomas W. Sweet Chief Financial Officer, Dell Technologies. Westminster, CO | $69.0M |
| 2010 | Victor L. Richey Jr. Insider, ESCO Technologies. St. Louis, MO | $69.0M |
Other Immunome insiders
All IMNM insiders- Michael Rapp$17.8MDirector. #5660 overall
- Clay B. Siegall$14.5MPresident and CEO. #6141 overall
- Philip Wagenheim$5.7MDirector. #4856 overall
- John L. Lamattina$1.1MDirector. #9629 overall
- Jean Jacques Bienaime$721KDirector. #2620 overall
Questions
How much stock does Isaac Barchas own?
Isaac Barchas holds $69,194,337 in listed stock based on SEC filings and current prices, mostly Immunome (IMNM). That ranks 2007th on the Stock Rich List.
Is this Isaac Barchas's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Isaac Barchas last buy or sell stock?
The most recent open-market trade on file is a sale of 11,048 IMNM shares on Aug 12, 2026 at $27.25.